The FDA has approved Gilead's Epclusa (sofosbuvir+velpatasvir) for hepatitis C, the first interferon-free combination treatment for all six major forms of the virus. The drug represented the next ...
Hepatitis C is liver inflammation and damage caused by infection with the hepatitis C virus. Hep C can cause a mild illness that lasts a short time (acute) or a serious illness that can last the rest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback